These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 28577207)

  • 41. On the pathophysiology of vitiligo: possible treatment options.
    Boissy RE; Dell'Anna ML; Picardo M
    Indian J Dermatol Venereol Leprol; 2012; 78(1):24-9. PubMed ID: 22199057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term results of split-skin grafting in combination with excimer laser for stable vitiligo.
    Al-Mutairi N; Manchanda Y; Al-Doukhi A; Al-Haddad A
    Dermatol Surg; 2010 Apr; 36(4):499-505. PubMed ID: 20180833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [EFFICACY OF COMBINED USE OF ANTIOXIDATIVE AND PHOTOTHERAPY IN THE TREATMENT OF VITILIGO].
    Tsiskarishvili NI; Katsitadze A; Tsiskarishvili NV; Tsiskarishvili T; Chitanava L
    Georgian Med News; 2016 Nov; (Issue):52-57. PubMed ID: 28009316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter.
    Park OJ; Park GH; Choi JR; Jung HJ; Oh ES; Choi JH; Lee MW; Chang SE
    Clin Exp Dermatol; 2016 Apr; 41(3):236-41. PubMed ID: 26299799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: a proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment.
    Lee KY; Jeon SY; Hong JW; Choi KW; Lee CY; Choi SJ; Kim JH; Song KH; Kim KH
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):609-16. PubMed ID: 22404745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitiligo treatment update.
    Daniel BS; Wittal R
    Australas J Dermatol; 2015 May; 56(2):85-92. PubMed ID: 25495880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding autoimmunity of vitiligo and alopecia areata.
    Rork JF; Rashighi M; Harris JE
    Curr Opin Pediatr; 2016 Aug; 28(4):463-9. PubMed ID: 27191524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response.
    Yang Q; Zhang G; Su M; Leung G; Lui H; Zhou P; Wu Y; Zhou J; Xu J; Zhang X; Zhou Y
    Front Immunol; 2021; 12():613031. PubMed ID: 33815367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Excimer light therapy in childhood segmental vitiligo: Early treatment gives better results.
    Majid I; Imran S
    Dermatol Ther; 2020 May; 33(3):e13408. PubMed ID: 32304121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.
    Grimes PE; Hamzavi I; Lebwohl M; Ortonne JP; Lim HW
    JAMA Dermatol; 2013 Jan; 149(1):68-73. PubMed ID: 23407924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixed vitiligo of Blaschko lines: a newly discovered presentation of vitiligo responsive to combination treatment.
    Kovacevic M; Stanimirovic A; Vucic M; Goren A; Situm M; Lukinovic Skudar V; Lotti T
    Dermatol Ther; 2016 Jul; 29(4):240-3. PubMed ID: 26970077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LRP1/CD91 is highly expressed in monocytes from patients with vitiligo - even after repigmentation.
    Piquero-Casals J; Martínez-Martínez L; Alomar A; Rozas-Muñoz E; Juarez C; Puig L
    Exp Dermatol; 2021 Mar; 30(3):390-395. PubMed ID: 33249636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K; Malakar S; Sarma N; Banerjee U
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current and emerging treatments for vitiligo.
    Rodrigues M; Ezzedine K; Hamzavi I; Pandya AG; Harris JE;
    J Am Acad Dermatol; 2017 Jul; 77(1):17-29. PubMed ID: 28619557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration.
    Park JH; Park SW; Lee DY; Lee JH; Yang JM
    Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):103-5. PubMed ID: 23458396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo.
    Yu HS; Wu CS; Yu CL; Kao YH; Chiou MH
    J Invest Dermatol; 2003 Jan; 120(1):56-64. PubMed ID: 12535198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.